Newsletter

BioMedReports Orexigen Therapeutics, Inc. (NASDAQ:OREX) stock surges as Mysimba gets European approval: Orexigen Therapeuti... http://t.co/kx3IQxiSKV
BioMedReports Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study; pSivida Completes Targeted Enrollme... http://t.co/SbqW0QaKPV
BioMedReports Rosetta Genomics Ltd. (USA) (NASDAQ:ROSG) gets US Patent for its unique Kidney Cancer Test: Shares of discount canadian cialis Rosetta... http://t.co/wVd2nOFLru